top of page
RTK crop.jfif

Corporate Financial Advisor and Board Level structuralist for Financial Analysis, Reporting, Accounting, Management Consulting, Healthcare Consulting and Corporate Law.  Financial executive and business consultant as Principal of a successful investment banking firm and legal advisory group, managing companies from startup to $40,000,000 in annual revenues in the biotech/life science, ophthalmic, and renewable energy sectors.

 

Rob Kirk, JD, OD

Founder and President of Metis Strategies, a management consultant and executive advisor to founders, CEOs, and leadership teams navigating growth, transition, and exit. Over a 30-year career, he has advised organizations across North America, Europe, and China on aligning strategy, leadership, and execution to drive margin, scalability, and enterprise value.

He has also served in interim CEO and C-suite roles and supported operational due diligence, EBITDA improvement, and post-acquisition integration.

 

Christopher D. Kline, PhD

Edward Hlozek, CEO and Chairman

CEO of Mind & Associates, Inc., Edward has been a senior level business executive, founder and Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic, gynecologic and ENT markets.

He has been responsible for financial and clinical introductory oversight for Class I, II & III devices for minimally invasive devices and techniques in all surgical specialties, including RF therapy devices. Designer and patent holder for the current transcatheter platform technologies of ValveCure.

Scientific Advisory Board​

  • David Adams, MD 
  • Peter Block, MD
  • Randy Chitwood, MD
  • Saibal Kar, MD
  • Jeffrey Milliken, MD
bottom of page